EP2547353
Medical use of a therapeutic combination comprising a thymosin-1-alpha polypeptide and a replication competent retroviral vector for the expression of cytosine deaminase.
:
EP einkaleyfi: Þýðing ekki lögð inn:
29.3.2011:
6.3.2019:
11766479.7
:
28.3.2031
:
Medical use of a therapeutic combination comprising a thymosin-1-alpha polypeptide and a replication competent retroviral vector for the expression of cytosine deaminase.
29.3.2011
6.3.2019
:
Tocagen Inc.:
3030 Bunker Hill Street Suite 230, 92109, San Diego, CA, US
:
GRUBER, Harry, E.:
Rancho Santa Fe, CA, US
:
JOLLY, Douglas, J.:
Encinitas, CA, US
:
PEREZ, Omar:
San Diego, CA, US
:
OSTERTAG, Derek, G.:
San Diego, CA, US
:
ROBBINS, Joan, M.:
San Diego, CA, US
:
318728 P:
29.3.2010:
US
:
US2011030402:
29.3.2011
:
A61K 38/16, A61K 38/17, A61K 38/22, A61K 48/00, C12N 15/86, C12N 15/867, A61P 35/00, C12N 9/78